Style | Citing Format |
---|---|
MLA | Amelimojarad M, Amelimojarad M, Pourmadian A. "Simvastatin Therapy Increased Mir-150-5P Expression in the Patients With Type 2 Diabetes and Covid-19." Cellular Physiology and Biochemistry, vol. 56, no. 6, 2022, pp. 685-691. |
APA | Amelimojarad M, Amelimojarad M, Pourmadian A (2022). Simvastatin Therapy Increased Mir-150-5P Expression in the Patients With Type 2 Diabetes and Covid-19. Cellular Physiology and Biochemistry, 56(6), 685-691. |
Chicago | Amelimojarad M, Amelimojarad M, Pourmadian A. "Simvastatin Therapy Increased Mir-150-5P Expression in the Patients With Type 2 Diabetes and Covid-19." Cellular Physiology and Biochemistry 56, no. 6 (2022): 685-691. |
Harvard | Amelimojarad M, Amelimojarad M, Pourmadian A (2022) 'Simvastatin Therapy Increased Mir-150-5P Expression in the Patients With Type 2 Diabetes and Covid-19', Cellular Physiology and Biochemistry, 56(6), pp. 685-691. |
Vancouver | Amelimojarad M, Amelimojarad M, Pourmadian A. Simvastatin Therapy Increased Mir-150-5P Expression in the Patients With Type 2 Diabetes and Covid-19. Cellular Physiology and Biochemistry. 2022;56(6):685-691. |
BibTex | @article{ author = {Amelimojarad M and Amelimojarad M and Pourmadian A}, title = {Simvastatin Therapy Increased Mir-150-5P Expression in the Patients With Type 2 Diabetes and Covid-19}, journal = {Cellular Physiology and Biochemistry}, volume = {56}, number = {6}, pages = {685-691}, year = {2022} } |
RIS | TY - JOUR AU - Amelimojarad M AU - Amelimojarad M AU - Pourmadian A TI - Simvastatin Therapy Increased Mir-150-5P Expression in the Patients With Type 2 Diabetes and Covid-19 JO - Cellular Physiology and Biochemistry VL - 56 IS - 6 SP - 685 EP - 691 PY - 2022 ER - |